Danaher Corporation  

(Public, NYSE:DHR)   Watch this stock  
Find more results for DHR
77.59
-0.08 (-0.10%)
Sep 23 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 77.34 - 77.83
52 week 76.15 - 102.79
Open 77.45
Vol / Avg. 0.00/2.98M
Mkt cap 53.52B
P/E 19.76
Div/yield 0.12/0.64
EPS 3.93
Shares 690.54M
Beta 1.13
Inst. own 78%
Dec 15, 2016
Danaher Corp 2016 Investor & Analyst Meeting - 10:00AM EST - Add to calendar
Oct 20, 2016
Q3 2016 Danaher Corp Earnings Call - 8:00AM EDT - Add to calendar
Oct 20, 2016
Q3 2016 Danaher Corp Earnings Release - 6:00AM EDT - Add to calendar
Sep 15, 2016
Danaher Corp at Morgan Stanley Laguna Conference - Webcast
Sep 7, 2016
Danaher Corp at Vertical Research Industrial Conference
Sep 6, 2016
Danaher Corp to Acquire Cepheid - M&A Call
Jul 25, 2016
Q2 2016 Danaher Corp Earnings Call
Jul 25, 2016
Q2 2016 Danaher Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '16) 2015
Net profit margin 11.35% 12.64%
Operating margin 17.88% 16.87%
EBITD margin - 22.58%
Return on average assets 5.27% 6.10%
Return on average equity 10.63% 11.04%
Employees 81,000 -
CDP Score - 22

Address

2200 Pennsylvania Ave NW Ste 800w
WASHINGTON, DC 20037-1731
United States - Map
+1-202-8280850 (Phone)
+1-202-8280860 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services. Its Environmental segment products and services help protect the water supply, enhance the safety of personal data and improve business efficiencies. In the Life Sciences & Diagnostics segment, its diagnostics business offers analytical instruments, reagents, consumables, software and services. Its life sciences business offers research tools. Its Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. Its Industrial Technologies segment solutions help protect the world's food supply, improve packaging design and quality, and verify pharmaceutical dosages.

Officers and directors

Steven M. Rales Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel L. Comas Chief Financial Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William K. Daniel II Executive Vice President
Age: 51
Bio & Compensation  - Reuters
Robert S. Lutz Senior Vice President, Chief Accounting Officer
Age: 58
Bio & Compensation  - Reuters
Brian W. Ellis Senior Vice President, General Counsel
Age: 49
Bio & Compensation  - Reuters
Angela S. Lalor Senior Vice President - Human Resources
Age: 50
Bio & Compensation  - Reuters
William H. King Senior Vice President- Strategic Development
Age: 48
Bio & Compensation  - Reuters
Daniel A. Raskas Senior Vice President - Corporate Development
Age: 49
Bio & Compensation  - Reuters
Thomas Patrick Joyce Jr. President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Donald J. Ehrlich Lead Independent Director
Age: 78
Bio & Compensation  - Reuters